CONTEXT: An increasing number of older adults are being treated for end-stage renal disease (ESRD) with long-term dialysis. OBJECTIVES: To determine how ESRD treatment practices for older adults vary across regions with differing end-of-life intensity of care. DESIGN, SETTING, AND PARTICIPANTS: Retrospective observational study using a national ESRD registry to identify a cohort of 41,420 adults (of white or black race), aged 65 years or older, who started long-term dialysis or received a kidney transplant between June 1, 2005, and May 31, 2006. Regional end-of-life intensity of care was defined using an index from the Dartmouth Atlas of Healthcare. MAIN OUTCOME MEASURES: Incidence of treated ESRD (dialysis or transplant), preparedness for ESRD (under the care of a nephrologist, having a fistula [vs graft or catheter] at time of hemodialysis initiation), and end-of-life care practices. RESULTS: Among whites, the incidence of ESRD was progressively higher in regions with greater intensity of care and this trend was most pronounced at older ages. Among blacks, a similar relationship was present only at advanced ages (men aged > or = 80 years and women aged > or = 85 years). Patients living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to be under the care of a nephrologist before the onset of ESRD (62.3% [95% confidence interval {CI}, 61.3%-63.3%] vs 71.1% [95% CI, 69.9%-72.2%], respectively) and less likely to have a fistula (vs graft or catheter) at the time of hemodialysis initiation (11.2% [95% CI, 10.6%-11.8%] vs 16.9% [95% CI, 15.9%-17.8%]). Among patients who died within 2 years of ESRD onset (n = 21,190), those living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to have discontinued dialysis before death (22.2% [95% CI, 21.1%-23.4%] vs 44.3% [95% CI, 42.5%-46.1%], respectively), less likely to have received hospice care (20.7% [95% CI, 19.5%-21.9%] vs 33.5% [95% CI, 31.7%-35.4%]), and more likely to have died in the hospital (67.8% [95% CI, 66.5%-69.1%] vs 50.3% [95% CI, 48.5%-52.1%]). These differences persisted in adjusted analyses. CONCLUSION: There are pronounced regional differences in treatment practices for ESRD in older adults that are not explained by differences in patient characteristics.
CONTEXT: An increasing number of older adults are being treated for end-stage renal disease (ESRD) with long-term dialysis. OBJECTIVES: To determine how ESRD treatment practices for older adults vary across regions with differing end-of-life intensity of care. DESIGN, SETTING, AND PARTICIPANTS: Retrospective observational study using a national ESRD registry to identify a cohort of 41,420 adults (of white or black race), aged 65 years or older, who started long-term dialysis or received a kidney transplant between June 1, 2005, and May 31, 2006. Regional end-of-life intensity of care was defined using an index from the Dartmouth Atlas of Healthcare. MAIN OUTCOME MEASURES: Incidence of treated ESRD (dialysis or transplant), preparedness for ESRD (under the care of a nephrologist, having a fistula [vs graft or catheter] at time of hemodialysis initiation), and end-of-life care practices. RESULTS: Among whites, the incidence of ESRD was progressively higher in regions with greater intensity of care and this trend was most pronounced at older ages. Among blacks, a similar relationship was present only at advanced ages (men aged > or = 80 years and women aged > or = 85 years). Patients living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to be under the care of a nephrologist before the onset of ESRD (62.3% [95% confidence interval {CI}, 61.3%-63.3%] vs 71.1% [95% CI, 69.9%-72.2%], respectively) and less likely to have a fistula (vs graft or catheter) at the time of hemodialysis initiation (11.2% [95% CI, 10.6%-11.8%] vs 16.9% [95% CI, 15.9%-17.8%]). Among patients who died within 2 years of ESRD onset (n = 21,190), those living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to have discontinued dialysis before death (22.2% [95% CI, 21.1%-23.4%] vs 44.3% [95% CI, 42.5%-46.1%], respectively), less likely to have received hospice care (20.7% [95% CI, 19.5%-21.9%] vs 33.5% [95% CI, 31.7%-35.4%]), and more likely to have died in the hospital (67.8% [95% CI, 66.5%-69.1%] vs 50.3% [95% CI, 48.5%-52.1%]). These differences persisted in adjusted analyses. CONCLUSION: There are pronounced regional differences in treatment practices for ESRD in older adults that are not explained by differences in patient characteristics.
Authors: Fliss E M Murtagh; James E Marsh; Paul Donohoe; Nasirul J Ekbal; Neil S Sheerin; Fiona E Harris Journal: Nephrol Dial Transplant Date: 2007-04-04 Impact factor: 5.992
Authors: Lih-Wen Mau; Jiannong Liu; Yang Qiu; Haifeng Guo; Areef Ishani; Thomas J Arneson; David T Gilbertson; Stephan C Dunning; Allan J Collins Journal: Am J Kidney Dis Date: 2010-02-08 Impact factor: 8.860
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: Anne M Murray; Cheryl Arko; Shu-Cheng Chen; David T Gilbertson; Alvin H Moss Journal: Clin J Am Soc Nephrol Date: 2006-09-06 Impact factor: 8.237
Authors: Jean L Holley; Sharon S Carmody; Alvin H Moss; Amy M Sullivan; Lewis M Cohen; Susan D Block; Robert M Arnold Journal: Am J Kidney Dis Date: 2003-10 Impact factor: 8.860
Authors: Sanjay Aneja; Joseph S Ross; Yongfei Wang; Masatoshi Matsumoto; George P Rodgers; Susannah M Bernheim; Saif S Rathore; Harlan M Krumholz Journal: Health Aff (Millwood) Date: 2011-12 Impact factor: 6.301
Authors: Bradley A Erickson; Xin Lu; Mary Vaughan-Sarrazin; Karl J Kreder; Benjamin N Breyer; Peter Cram Journal: Urology Date: 2013-11-25 Impact factor: 2.649
Authors: Susan P Y Wong; Paul L Hebert; Ryan J Laundry; Kenric W Hammond; Chuan-Fen Liu; Nilka R Burrows; Ann M O'Hare Journal: Clin J Am Soc Nephrol Date: 2016-09-22 Impact factor: 8.237
Authors: Bernadette A Thomas; Rudolph A Rodriguez; Edward J Boyko; Cassianne Robinson-Cohen; Annette L Fitzpatrick; Ann M O'Hare Journal: Clin J Am Soc Nephrol Date: 2013-04-11 Impact factor: 8.237
Authors: Guofen Yan; Alfred K Cheung; Jennie Z Ma; Alison J Yu; Tom Greene; M Norman Oliver; Wei Yu; Keith C Norris Journal: Clin J Am Soc Nephrol Date: 2013-03-14 Impact factor: 8.237